GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » 12-1 Month Momentum %

Gujarat Terce Laboratories (BOM:524314) 12-1 Month Momentum % : 189.65% (As of May. 11, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-11), Gujarat Terce Laboratories's 12-1 Month Momentum % is 189.65%.

The industry rank for Gujarat Terce Laboratories's 12-1 Month Momentum % or its related term are showing as below:

BOM:524314's 12-1 Month Momentum % is ranked better than
97.75% of 1109 companies
in the Drug Manufacturers industry
Industry Median: -6.39 vs BOM:524314: 189.65

Competitive Comparison of Gujarat Terce Laboratories's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Terce Laboratories's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's 12-1 Month Momentum % falls into.



Gujarat Terce Laboratories  (BOM:524314) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Terce Laboratories  (BOM:524314) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Gujarat Terce Laboratories 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Terce Laboratories (BOM:524314) Business Description

Traded in Other Exchanges
N/A
Address
Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines